Ironwood Pharmaceuticals Current Ratio 2009-2020 | IRWD

Ironwood Pharmaceuticals current ratio from 2009 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Ironwood Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.43B $0.03B 13.17
2020-06-30 $0.37B $0.03B 14.02
2020-03-31 $0.33B $0.03B 12.10
2019-12-31 $0.31B $0.04B 7.50
2019-09-30 $0.26B $0.05B 4.88
2019-06-30 $0.22B $0.11B 1.99
2019-03-31 $0.20B $0.12B 1.70
2018-12-31 $0.27B $0.12B 2.23
2018-09-30 $0.25B $0.11B 2.21
2018-06-30 $0.28B $0.10B 2.94
2018-03-31 $0.28B $0.06B 4.42
2017-12-31 $0.31B $0.07B 4.72
2017-09-30 $0.31B $0.06B 4.87
2017-06-30 $0.34B $0.08B 4.27
2017-03-31 $0.36B $0.08B 4.54
2016-12-31 $0.38B $0.09B 4.17
2016-09-30 $0.38B $0.10B 4.02
2016-06-30 $0.39B $0.09B 4.24
2016-03-31 $0.50B $0.08B 6.35
2015-12-31 $0.50B $0.08B 6.54
2015-09-30 $0.51B $0.07B 7.46
2015-06-30 $0.53B $0.06B 8.49
2015-03-31 $0.26B $0.06B 4.41
2014-12-31 $0.29B $0.06B 4.76
2014-09-30 $0.30B $0.05B 5.63
2014-06-30 $0.33B $0.04B 7.83
2014-03-31 $0.37B $0.04B 9.64
2013-12-31 $0.23B $0.04B 5.58
2013-09-30 $0.28B $0.04B 6.95
2013-06-30 $0.34B $0.04B 7.64
2013-03-31 $0.28B $0.06B 4.40
2012-12-31 $0.18B $0.06B 3.36
2012-09-30 $0.20B $0.04B 5.69
2012-06-30 $0.17B $0.05B 3.38
2012-03-31 $0.21B $0.05B 3.95
2011-12-31 $0.17B $0.07B 2.57
2011-09-30 $0.18B $0.07B 2.52
2011-06-30 $0.21B $0.07B 2.94
2011-03-31 $0.23B $0.06B 3.78
2010-12-31 $0.26B $0.06B 4.02
2010-09-30 $0.26B $0.06B 4.71
2010-06-30 $0.28B $0.06B 4.93
2010-03-31 $0.31B $0.06B 5.57
2009-12-31 $0.13B $0.06B 2.33
2009-09-30 $0.12B $0.05B 2.30
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
2008-12-31 $0.11B $0.04B 2.87
2008-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.862B $0.428B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.133B 41.50
Takeda Pharmaceutical (TAK) Japan $55.867B 10.42
Astellas Pharma (ALPMY) Japan $28.839B 18.01
Eisai (ESALY) Japan $21.946B 19.12
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $19.813B 25.98
Catalent (CTLT) United States $15.589B 46.63
Grifols, S.A (GRFS) Spain $12.520B 14.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.500B 23.81
Neurocrine Biosciences (NBIX) United States $8.887B 69.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.561B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.902B 12.77
IPSEN SA ADR (IPSEY) France $7.862B 0.00
Ionis Pharmaceuticals (IONS) United States $7.025B 68.82
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.003B 12.78
Arrowhead Pharmaceuticals (ARWR) United States $5.859B 0.00
Evotec AG (EVTCY) Germany $4.893B 332.50
PTC Therapeutics (PTCT) United States $4.335B 0.00
Sage Therapeutics (SAGE) United States $4.304B 0.00
Hypermarcas (HYPMY) Brazil $3.756B 13.81
ChemoCentryx (CCXI) United States $3.737B 0.00
FibroGen (FGEN) United States $3.642B 0.00
Nektar Therapeutics (NKTR) United States $2.956B 0.00
Cronos Group (CRON) Canada $2.839B 0.00
Revolution Medicines (RVMD) United States $2.776B 0.00
Pacira BioSciences (PCRX) United States $2.753B 59.77
Corcept Therapeutics (CORT) United States $2.652B 25.65
Taro Pharmaceutical Industries (TARO) Israel $2.623B 13.39
Xencor (XNCR) United States $2.354B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.768B 0.00
Trillium Therapeutics (TRIL) Canada $1.711B 0.00
Heron Therapeutics (HRTX) United States $1.613B 0.00
USANA Health Sciences (USNA) United States $1.594B 14.03
Translate Bio (TBIO) United States $1.355B 0.00
Indivior (INVVY) United States $1.235B 15.31
Endo (ENDP) Ireland $1.221B 1.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.193B 8.29
Ocular Therapeutix (OCUL) United States $1.179B 0.00
Zogenix (ZGNX) United States $1.174B 0.00
Karyopharm Therapeutics (KPTI) United States $1.086B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.081B 0.00
Tilray (TLRY) Canada $0.997B 0.00
ImmunoGen (IMGN) United States $0.994B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.840B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.783B 0.00
Esperion Therapeutics (ESPR) United States $0.752B 0.00
Radius Health (RDUS) United States $0.751B 0.00
VAXART, INC (VXRT) United States $0.701B 0.00
Collegium Pharmaceutical (COLL) United States $0.666B 39.33
Spectrum Pharmaceuticals (SPPI) United States $0.665B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.88
Aerie Pharmaceuticals (AERI) United States $0.596B 0.00
Chinook Therapeutics (KDNY) United States $0.577B 0.00
Organogenesis Holdings (ORGO) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.547B 15.37
Ardelyx (ARDX) United States $0.545B 0.00
Flexion Therapeutics (FLXN) United States $0.535B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.495B 0.00
Akebia Therapeutics (AKBA) United States $0.477B 0.00
Molecular Templates (MTEM) United States $0.442B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.430B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.426B 0.00
Innate Pharma SA (IPHYF) France $0.407B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
DURECT (DRRX) United States $0.378B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Profound Medical (PROF) Canada $0.366B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.362B 9.43
Calithera Biosciences (CALA) United States $0.341B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
Altimmune (ALT) United States $0.334B 0.00
KalVista Pharmaceuticals (KALV) United States $0.333B 0.00
Rafael Holdings (RFL) United States $0.327B 0.00
MEI Pharma (MEIP) United States $0.326B 0.00
Redhill Biopharma (RDHL) Israel $0.320B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
Summit Therapeutics (SMMT) United States $0.288B 0.00
Menlo Therapeutics (VYNE) United States $0.277B 0.00
CTI BioPharma (CTIC) United States $0.276B 0.00
Jounce Therapeutics (JNCE) United States $0.267B 0.00
Lannett Co Inc (LCI) United States $0.261B 6.90
Nature's Sunshine Products (NATR) United States $0.244B 15.71
IMV INC (IMV) Canada $0.231B 0.00
Aquestive Therapeutics (AQST) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.224B 0.00
OptiNose (OPTN) United States $0.222B 0.00
Alpine Immune Sciences (ALPN) United States $0.216B 0.00
Otonomy (OTIC) United States $0.207B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Heat Biologics (HTBX) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.126B 0.00
Infinity Pharmaceuticals (INFI) United States $0.116B 0.00
Lipocine (LPCN) United States $0.107B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.099B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
KemPharm (KMPH) United States $0.080B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Biomerica (BMRA) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
ElectroCore (ECOR) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.065B 125.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Addex Therapeutics (ADXN) Switzerland $0.061B 0.00
GTx (ONCT) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 22.39
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.68
Opiant Pharmaceuticals (OPNT) United States $0.035B 0.00
Vical (BBI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Sundial Growers (SNDL) Canada $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
PolarityTE (PTE) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.016B 27.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Shineco (TYHT) China $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00